Evaluation of Safety and Efficiency of Metreleptin Treatment for Patients With Multiple Symmetric Lipomatosis (MSL)
Evaluation of Safety and Efficiency of Metreleptin Treatment for Patients With Multiple Symmetric Lipomatosis (MSL)
Active, not recruiting · NCT05351164 · Registry updated 2025-06-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of Safety and Efficiency of Metreleptin Treatment for Patients With Multiple Symmetric Lipomatosis (MSL) | Lipid Metabolism Disorders, Lipomatosis, Multiple Symmetrical, Nutritional and Metabolic Diseases, Skin and Connective Tissue Diseases, lipomatosis, metabolic disease, skin disorder | Active, not recruiting | Phase 2 | 2025-06-12 | NCT05351164 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Amryt Pharma | 2 |
| University of Michigan | 394 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Michigan | Ann Arbor | United States | 538 |